Checkpoint Immunotherapy for Melanoma and Advanced Cancer: Current and Novel Targets
Dr. Jason Luke, assistant professor of medicine, explains the basic aspects as well as biomarkers of an effective antitumor immune response and reviews data from completed immunotherapy trials for melanoma and advanced cancers. Dr. Luke also outlines novel drug targets and rational combination immunotherapy strategies
Published
May 19, 2016
Created by
Related Presenters
Assistant Professor of Medicine
A medical oncologist, Jason Luke, MD, FACP, cares for patients with melanoma and advanced solid tumors. In the context of a multidisciplinary team of doctors and nurses, Dr. Luke works to bring a personalized approach to each patient through ...